Last reviewed · How we verify
NCT05928247
Manualized Assessment and Treatment Model of Challenging Behavior
NA trial testing Functional Communication Training (FCT) in Problem Behavior in 30 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Rutgers, The State University of New Jersey |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 30 January 2026 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Functional Communication Training (FCT)
- Non-Contingent Reinforcement (NCR)
- Competing Items and Response Blocking
- Research Units in Behavioral Intervention (RUBI) protocol
Conditions studied
- Problem Behavior — all drugs for Problem Behavior →
- Aggression — all drugs for Aggression →
- Self-Injury — all drugs for Self-Injury →
Sponsor
Rutgers, The State University of New Jersey
Who can join
Adults 3 to 17, any sex, with Problem Behavior or Aggression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Despite decades of mounting single-case-design evidence for the efficacy of applied behavior analysis (ABA) and other approaches for the assessment and treatment of challenging behavior, an evidence-based comprehensive approach remains to exist. The current study will collect test the efficacy of a standardized manual for assessing and treating challenging behavior for individuals with severe and mild challenging behavior.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05928247
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Problem Behavior
Currently open trials in the same condition.
- NCT06651606 — Preventing Relapse of Problem Behavior Through Behavioral Economics: A Translational Analysis · NA · recruiting
- NCT05925101 — Basic and Applied Research on Extinction Bursts · NA · recruiting
- NCT05537610 — Extensions of Resurgence as Choice · NA · recruiting
- NCT05649839 — Design of a Prototype Garment Adapted to Demented Elderly Subjects With Disturbing Behavioral Problems in the Management · NA · active not recruiting
- NCT05217615 — Parent Training for Parents of Toddlers Born Very Premature: · NA · active not recruiting
Other Rutgers, The State University of New Jersey trials
Trials by the same sponsor.
- NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD) · NA · not yet recruiting
- NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis · NA · not yet recruiting
- NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma · Phase 2 · not yet recruiting
- NCT07525011 — Comparative Study of Denture Fabrication Techniques · NA · not yet recruiting
- NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05928247 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
- Last refreshed: 11 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05928247.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing